XML 28 R19.htm IDEA: XBRL DOCUMENT v3.23.3
Stock Plans (Tables)
9 Months Ended
Sep. 30, 2023
Share-Based Payment Arrangement [Abstract]  
Schedule of our option activity
                    
   Options
(in thousands)
   Weighted Average
Exercise Price
per share
   Weighted Average
Remaining Option
Term (in years)
   Aggregate Intrinsic
Value
(in thousands)
 
Outstanding at December 31, 2022   927   $7.97    8.34   $- 
Granted   1,475    0.93    -    235 
Forfeited or expired   (91)   23.01    -    - 
Outstanding at September 30, 2023   2,311    2.89    8.84    213 
Exercisable at September 30, 2023   2,311    2.89    8.84    213 
Schedule of the stock-based compensation expense
                    
   Three Months Ended   Nine Months Ended 
   September 30,   September 30, 
(in thousands)  2023   2022   2023   2022 
Research and development  $52   $306   $106   $553 
Selling, general and administrative   359    217    859    414 
Total stock-based compensation  $411   $523   $965   $967 
Schedule of assumptions to estimate the fair value of options
                    
   Three Months Ended   Nine Months Ended 
   September 30,   September 30, 
   2023   2022   2023   2022 
Weighted-average risk-free interest rate   4.08%   -%   4.06%   1.91%
Expected dividend payments   -    -    -    - 
Expected holding period (years)1   4.8    -    5.3    5.3 
Weighted-average volatility factor2   1.14    -    1.10    1.16 
Estimated forfeiture rates for options granted3   7.5%   -%   7.0%   5.6%

 

 
(1) Expected holding period is based on historical experience of similar awards, giving consideration to the contractual terms of the stock-based awards, vesting schedules and the expectations of future employee behavior.
(2) Weighted average volatility is based on the historical volatility of our common stock.
(3) Estimated forfeiture rates are based on historical data.